公式動画ピックアップ
AAPL
ADBE
ADSK
AIG
AMGN
AMZN
BABA
BAC
BL
BOX
C
CHGG
CLDR
COKE
COUP
CRM
CROX
DDOG
DELL
DIS
DOCU
DOMO
ESTC
F
FIVN
GILD
GRUB
GS
GSK
H
HD
HON
HPE
HSBC
IBM
INST
INTC
INTU
IRBT
JCOM
JNJ
JPM
LLY
LMT
M
MA
MCD
MDB
MGM
MMM
MSFT
MSI
NCR
NEM
NEWR
NFLX
NKE
NOW
NTNX
NVDA
NYT
OKTA
ORCL
PD
PG
PLAN
PS
RHT
RNG
SAP
SBUX
SHOP
SMAR
SPLK
SQ
TDOC
TEAM
TSLA
TWOU
TWTR
TXN
UA
UAL
UL
UTX
V
VEEV
VZ
WDAY
WFC
WK
WMT
WORK
YELP
ZEN
ZM
ZS
ZUO
公式動画＆関連する動画 [AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research]
AI in drug discovery is reshaping biotechnology, precision medicine, and pharmaceutical R&D. In this episode of Meeting the Moment, scientists from Amgen, MIT, and Harvard explore how artificial intelligence, machine learning, protein modeling, and computational biology are changing the future of medicine development.
Moderated by Charles Lin, Executive Director at Amgen, this roundtable discussion examines some of the biggest questions in AI-driven drug discovery and biomedical research:
• Can AI accelerate the discovery and development of new medicines?
• How are protein language models and AlphaFold transforming drug discovery?
• What role do generative AI, predictive modeling, and biological datasets play in therapeutic development?
• Where does human expertise remain essential in AI-powered science?
The panel explores the opportunities and limitations of AI in biotech, including biological complexity, protein interactions, immunogenicity, data quality, computational biology, and translating AI predictions into real-world therapies.
Featuring experts from Amgen, MIT, and Harvard Medical School, this conversation covers:
-AI in biotech and pharmaceutical innovation
-Machine learning for drug discovery
-Protein engineering and protein structure prediction
-Computational biology and systems biology
-AI-driven target discovery and molecular design
-Precision medicine and the future of therapeutics
Whether you work in biotechnology, pharma, AI research, bioinformatics, computational chemistry, or healthcare innovation, this discussion explores where AI is already making an impact — and what breakthroughs may come next.
Subscribe to the Amgen YouTube Science channel for more conversations on AI, drug development, biomedical innovation, and the future of medicine.
Panelists include Angela Koehler (PhD, Associate Director for Integrative Cancer Research, MIT), Sergey Ovchinnikov (PhD, Assistant Professor, MIT), Debora Marks (PhD, Professor, Harvard) and Kaiyi Jiang (PhD, Science Fellow, Amgen)
Find Amgen on the Web:
Facebook: https://bit.ly/35Xf09E
Instagram: https://bit.ly/2SYnTKJ
X: https://bit.ly/2SW2cLq
LinkedIn: https://bit.ly/2xWbS17
1065